Ingo Friedrich

Title: Ingo Friedrich: Innovator in Pharmaceutical Technologies

Introduction

Ingo Friedrich is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms and devices. With a total of 4 patents to his name, Friedrich's work has the potential to enhance drug delivery systems and improve patient outcomes.

Latest Patents

Friedrich's latest patents include a pharmaceutical dosage form comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. This formulation is designed for administration twice daily, once daily, or less frequently, and contains a physiologically acceptable salt of the compound. Another significant patent is for a pharmaceutical device that facilitates electric-field assisted administration of Tapentadol. This device includes at least one pair of electrodes and a drug reservoir, allowing for effective delivery of the medication through the skin.

Career Highlights

Throughout his career, Ingo Friedrich has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. His expertise in drug formulation and delivery has positioned him as a key player in the development of advanced pharmaceutical technologies.

Collaborations

Friedrich has collaborated with notable colleagues such as Nadja Gruening and Marc Schiller. These partnerships have contributed to the innovative projects he has undertaken in the pharmaceutical sector.

Conclusion

Ingo Friedrich's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication administration, paving the way for advancements in patient care.